Back
Arbutus Biopharma Vs. GlycoMimetics Industry Stock Comparison
Sell
27
ABUS
Arbutus Biopharma
Last Price:
$3.20
Seasonality Move:
21.65%
Sell
18
GLYC
GlycoMimetics
Last Price:
$0.23
Seasonality Move:
-6.72%
Sell
27
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
-
The current Arbutus Biopharma [ABUS] share price is $3.21. The Score for ABUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
GlycoMimetics (GLYC)
is a Sell
Is GlycoMimetics a Buy, Sell or Hold?
-
The current GlycoMimetics [GLYC] share price is $0.23. The Score for GLYC is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
GLYC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.21Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.
GLYC Stock Price Chart
What is GlycoMimetics's stock price today?
-
The GlycoMimetics share price today is $0.23The current trend is relatively stagnant and GLYC is experiencing slight buying pressure.
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 33.79 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.35 - 3.65) | Sell |
Bollinger Bands (100): | (3.53 - 4.11) | Sell |
GLYC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 39.32 | Sell |
Chaikin Money Flow: | 430722 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.35) | Sell |
Bollinger Bands (100): | (0.14 - 0.32) | Buy |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.41 | Sell |
20-day SMA: | 3.5 | Sell |
50-day SMA: | 3.71 | Sell |
200-day SMA: | 3.44 | Sell |
8-day EMA: | 3.37 | Sell |
20-day EMA: | 3.49 | Sell |
50-day EMA: | 3.63 | Sell |
200-day EMA: | 3.44 | Sell |
GLYC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.24 | Sell |
20-day SMA: | 0.28 | Sell |
50-day SMA: | 0.3 | Sell |
200-day SMA: | 0.7 | Sell |
8-day EMA: | 0.24 | Sell |
20-day EMA: | 0.27 | Sell |
50-day EMA: | 0.28 | Sell |
200-day EMA: | 0.66 | Sell |
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
GlycoMimetics Earnings Growth & GLYC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.
Arbutus Biopharma Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GlycoMimetics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |